Calming the storm: sedative tested as lifesaver for deadly heart rhythms

NCT ID NCT06281977

Summary

This study is testing whether a sedative medication called dexmedetomidine can help patients experiencing 'electrical storm'—a life-threatening condition where the heart's lower chambers beat dangerously fast and repeatedly. About 192 adults admitted to intensive care with this condition will receive either the drug or a placebo for 2-3 days as part of their initial treatment. The main goal is to see if the drug reduces the combined risk of dying in the hospital or having another dangerous heart rhythm event that needs treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Ottawa Heart Institute

    RECRUITING

    Ottawa, Ontario, K1Y 4W7, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.